JP2021535110A5 - - Google Patents
Info
- Publication number
- JP2021535110A5 JP2021535110A5 JP2021509758A JP2021509758A JP2021535110A5 JP 2021535110 A5 JP2021535110 A5 JP 2021535110A5 JP 2021509758 A JP2021509758 A JP 2021509758A JP 2021509758 A JP2021509758 A JP 2021509758A JP 2021535110 A5 JP2021535110 A5 JP 2021535110A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- group
- alkyl
- composition according
- bcl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1814207.5 | 2018-08-31 | ||
| GBGB1814207.5A GB201814207D0 (en) | 2018-08-31 | 2018-08-31 | Combination Therapy |
| GB1908225.4 | 2019-06-10 | ||
| GBGB1908225.4A GB201908225D0 (en) | 2019-06-10 | 2019-06-10 | Combination therapy |
| PCT/EP2019/073212 WO2020043878A1 (en) | 2018-08-31 | 2019-08-30 | Combination therapy |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021535110A JP2021535110A (ja) | 2021-12-16 |
| JP2021535110A5 true JP2021535110A5 (cg-RX-API-DMAC7.html) | 2022-08-29 |
| JP7590083B2 JP7590083B2 (ja) | 2024-11-26 |
Family
ID=67841060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021509758A Active JP7590083B2 (ja) | 2018-08-31 | 2019-08-30 | 併用療法 |
Country Status (16)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202113092WA (en) * | 2019-06-10 | 2021-12-30 | Adc Therapeutics Sa | Combination therapy comprising an anti-cd19 antibody drug conjugate and a pi3k inhibitor or a secondary agent |
| GB202011993D0 (en) | 2020-07-31 | 2020-09-16 | Adc Therapeutics Sa | ANTI-IL 13Ra2 antibodies |
| KR20240028449A (ko) * | 2021-06-29 | 2024-03-05 | 에이디씨 테라퓨틱스 에스에이 | 항체-약물 접합체를 이용한 병용 요법 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| NZ567140A (en) | 2005-10-07 | 2011-09-30 | Exelixis Inc | Azetidines as MEK inhibitors for the treatment of proliferative diseases |
| BR112015008238A2 (pt) | 2012-10-12 | 2017-11-28 | Adc Therapeutics Sarl | conjugados de pirrolbenzodiazepina-anticorpo anti-cd22 |
| DK2906298T3 (en) * | 2012-10-12 | 2018-12-17 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
| GB201506399D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
| GB201506402D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
| WO2017160954A1 (en) * | 2016-03-15 | 2017-09-21 | Seattle Genetics, Inc. | Combinations of pbd-based antibody drug conjugates with bcl-2 inhibitors |
| WO2018078123A1 (en) * | 2016-10-28 | 2018-05-03 | Morphosys Ag | Combination of anti cd19 antibody with a bcl-2 inhibitor and uses thereof |
| EP3612839A1 (en) * | 2017-04-20 | 2020-02-26 | ADC Therapeutics SA | Combination therapy |
| KR102442736B1 (ko) * | 2017-06-14 | 2022-09-16 | 에이디씨 테라퓨틱스 에스에이 | 항-cd19 adc의 투여를 위한 투약량 체제 |
-
2019
- 2019-08-30 CA CA3107085A patent/CA3107085A1/en active Pending
- 2019-08-30 BR BR112021003675-0A patent/BR112021003675A2/pt not_active Application Discontinuation
- 2019-08-30 MX MX2021001908A patent/MX2021001908A/es unknown
- 2019-08-30 JP JP2021509758A patent/JP7590083B2/ja active Active
- 2019-08-30 AU AU2019332979A patent/AU2019332979B2/en active Active
- 2019-08-30 ES ES19762358T patent/ES3037206T3/es active Active
- 2019-08-30 US US17/271,108 patent/US20210322564A1/en not_active Abandoned
- 2019-08-30 EP EP19762358.0A patent/EP3843748B1/en active Active
- 2019-08-30 KR KR1020217006539A patent/KR20210054520A/ko not_active Ceased
- 2019-08-30 IL IL280968A patent/IL280968B2/en unknown
- 2019-08-30 UA UAA202100248A patent/UA128954C2/uk unknown
- 2019-08-30 SG SG11202101518QA patent/SG11202101518QA/en unknown
- 2019-08-30 CN CN201980056828.XA patent/CN112638392B/zh active Active
- 2019-08-30 WO PCT/EP2019/073212 patent/WO2020043878A1/en not_active Ceased
-
2021
- 2021-01-22 ZA ZA2021/00467A patent/ZA202100467B/en unknown
- 2021-02-23 PH PH12021550376A patent/PH12021550376A1/en unknown